A Phase 1, Randomized, Double-blind, Placebo-controlled Study Evaluating AMG 691 in Healthy Participants and Participants With Mild-to-Moderate Asthma

NCT06637371 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

124

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

DRUG: AMG 691
DRUG: Placebo

Sponsor

Amgen